Mohamed Benlazar’s Post

Understanding the signs and symptoms of acute lymphoblastic leukemia (ALL) in children is crucial for early detection and treatment. From anemia to swollen lymph nodes, recognizing these indicators can make a significant difference in the journey of young patients battling leukemia. #ALLSeries #LeukemiaChallenges #TreatmentStruggles #SupportNeeded

We encourage you to take some time today to learn about the story of Alex Yang, a First Tee student diagnosed with T-cell acute lymphoblastic leukemia. Alex shares his perspective on his diagnosis, and his commitment to reaching his goals with the support of his community. Read the full story: https://lnkd.in/ghgWTjiA

Real-world data on the clinical & economic burden of chronic lymphocytic leukemia are limited. This article reports real-world characteristics, treatments, & costs of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in the US. #BloodCancerAwareness https://lnkd.in/eKQE4MUg

Keeping up with the ever-evolving landscape of chronic lymphocytic leukemia (CLL) therapies can be daunting. Discover how Therapyte proposes an #RWE solution to address this challenge in our latest case study. https://lnkd.in/eJjS-g6s #cll #bloodcancer #healthcareinnovation #therapyte

FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE

Benzene Exposure Linked to Acute Myeloid Leukemia, Aplastic Anemia, and Lymphomas https://hubs.ly/Q02xKtwQ0

Check out figure 7 in the discussion section. I love this figure and I had such a great time working on it! It took a while so I almost forgot about it. Such a lovely surprise to see this great paper is finally published!! (Link in the comments)

“Every single patient can teach us important lessons”. This landmark paper, published in the NEJM in 2013, highlights several fundamental principles for the management of #CAR_T-cell_therapy and its life-threatening complications through the publication of the very first two cases of children with acute lymphoblastic leukemia treated with this approach. https://lnkd.in/dkM354pz

Excited to share my latest paper, "Cannabinoid combination targets NOTCH1-mutated T-cell acute lymphoblastic leukemia through the integrated stress response pathway" https://lnkd.in/db4ZxB5s

Glad to share that our Abstract ID 142529 titled The Budget Impact of Venetoclax Plus Obinutuzumab for First-Line Chronic Lymphocytic Leukemia in Saudi Arabia has been accepted as a Poster Presentation to ISPOR Europe 2024 taking place 17-20 November at the Barcelona International Convention Center, Barcelona. Introducing VEN+G for a one-year fixed treatment duration for treating first-line CLL resulted in additional cost in the first 3 years, followed by savings in the consequent years resulting in net incremental savings of 223 thousand SAR over the time horizon. Fixed duration combination treatment over 1 year may offer better compliance to the patients and an emerging opportunity for TFR concept in CLL. #CLL14study, #CLL